PerkinElmer
check quantity

DELFIA Eu-labeled Goat Anti-HRP Toolbox Kit for ELISA Conversion (5 x 96-well ½AreaPlate)

DELFIA® Toolbox kits allow you to build your own DELFIA time-resolved fluorescence (TRF) assay using your preferred antibody against the analyte of interest. Painlessly switch your traditional ELISA to one with a wider dynamic range, higher sensitivity, and great signal stability. This kit contains all necessary reagents to perform a sandwiching immunoassay using DELFIA Europium-labeled goat anti-HRP antibody for detection.

For research use only; not for diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).

Part Number
Unit Size
List Price
Your Price
Quantity
DFA500-96S-1
1 stripwell plate
568.00 USD
 
more
DFA500-96S-5
5 stripwell plates
866.00 USD
 
more
DFA500-HALF-1
1½AreaPlate
560.00 USD
 
more
DFA500-HALF-5
5 ½AreaPlate
808.00 USD
 
more
Buy Now

Please enter valid quantity

Please log in to add favorites.

NULL OR EMPTY CART

Overview

Build your own assay for quantitative detection of target analyte in cell lysate, cell supernatant, tissue extract, serum, plasma, blood, and other sample types using DELFIA time-resolved fluorescence wash-based technology. DELFIA (Dissociation-enhanced lanthanide fluorescence immunoassay) TRF (time-resolved fluorescence) technology is a highly-sensitive wash-based immunoassay platform which utilizes a lanthanide chelate to reduce background and improve assay dynamic range. DELFIA offers significant advantages over traditional ELISA, while keeping a similar workflow:

  • High sensitivity
  • Wide dynamic range
  • Superior stability
  • Proven technology

DELFIA Toolbox Kits allow you to build your own DELFIA assay using your preferred antibody against the analyte of interest, bringing you the ability to painlessly switch your traditional ELISA to one with a wider dynamic range, higher sensitivity and great signal stability. These kits contain:

  • DELFIA Europium-labeled anti-HRP
  • DELFIA Wash Concentrate
  • DELFIA Assay Buffer
  • DELFIA Enhancement Solution
  • DTPA Purified BSA (7.5%)
  • 96-well Stripwell Plates or ½AreaPlates (high bind for direct coating of antibody)

Specifications

Assay Technology Time-Resolved Fluorescence (TRF), DELFIA TRF
Detection Method Time-Resolved Fluorescence (TRF), DELFIA TRF
Product Brand Name DELFIA TRF
Shipping Condition Blue Ice
Unit Size 5 ½AreaPlate
Resources, Events & More
  • All

Application Note

A Novel DELFIA Time-Resolved Fluorescence Biomarker Detection Assay with Superior Performance to Conventional ELISA

DELFIA® (Dissociated-Enhanced Lanthanide Fluorescent Immunoassay) TRF is a proven, robust immunodetection platform with over 20 years of history. DELFIA has a similar assay principle and workflow to that of a traditional ELISA, but with the added benefits of a stable, time-resolved fluorescent signal, and improved assay dynamic range.

Download this application note to see how DELFIA TRF outperforms ELISA as a robust assay providing high sensitivity, superior signal stability, and a wider dynamic range.

PDF 993 KB

Brochure

Drug Discovery Screening Solutions Brochure

Find out about our range of integrated solutions for drug discovery screening in this e-brochure.

Our screening solutions for high-throughput screening, phenotypic screening and data analysis help to streamline drug discovery workflows in labs across the globe. Our portfolio includes automated liquid handling, assays and reagents, imaging and detection systems, and informatics.

Working independently or together, with our solutions you can achieve consistent and accurate results. By accelerating the identification and characterization of effective and safe drug candidates, the PerkinElmer portfolio enables you to optimize efficiency in your lab and deliver more actionable, real-world results.

Download the brochure to learn more about how we can partner with you so that you can discover smarter, more effective, data-driven breakthroughs in the critical screening stages of drug discovery and development.

PDF 4 MB